Excessive naked megakaryocyte nuclei in myelodysplastic syndrome mimicking idiopathic thrombocytopenic purpura: A complicated pre- and post-transplantation course

Pediatric Hematology and Oncology

Volumn 26, Issue 6, 2009, Pages 387-397

  Olcay, Lale ^a   Tuncer, A Murat ^b   Okur, Hamza ^b   Erdemli, Esra ^c   Uysal, Zümrüt ^c   Çetin, Mualla ^b   Duru, Feride ^d,e   Çetinkaya, Duygu Uçkan ^b  

^a Unit of Pediatric Hematology   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c ANKARA UNIVERSITY   (Turkey)

^d DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^e ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Apoptosis; Dysmegakaryopoiesis; Myelodysplastic syndrome; Naked megakaryocyte nuclei; Refractory thrombocytopenia

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN A; CYTARABINE; ETOPOSIDE; IMMUNOGLOBULIN G; INTERLEUKIN 11; METHYLPREDNISOLONE; MITOXANTRONE; PREDNISOLONE; STEROID; VINCRISTINE;

APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; BRAIN HEMORRHAGE; CASE REPORT; CHILD; DRUG MEGADOSE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LOW DRUG DOSE; MALE; MEGAKARYOCYTE; MYELODYSPLASTIC SYNDROME; NAKED MEGAKARYOCYTE NUCLEUS; REFRACTORY THROMBOCYTOPENIA; SPLENECTOMY;

BONE MARROW TRANSPLANTATION; CASE-CONTROL STUDIES; CELL NUCLEUS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLOW CYTOMETRY; HUMANS; INFANT; MALE; MEGAKARYOCYTES; MYELODYSPLASTIC SYNDROMES; PLATELET COUNT; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 68649108160     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010902891891     Document Type: Article

References (26)

1. Menke DM, Colon-Otero G, Cockerill KJ, Jenkins RB, Noel P, Pierre RV. Refractory thrombocytopenia: a myelodysplastic syndrome that may mimic immune thrombocytopenic purpura. Am J Clin Pathol. 1992;98:502-510.
2. Rosati S, Mick R, Xu F, et al. Refractory cytopenia with multilineage dysplasia: further characterization of an 'Unclassifiable' myelodysplastic syndrome. Leukemia. 1996;10:20-26.
3. Brunning RD. Morphologic classifications of myelodysplastic syndromes: French-American-British (FAB) and World Health Organization (WHO). In: Greenberg PL, ed. Myelodysplastic Syndromes: Clinical and Biological Advances. Cambridge, UK: Cambridge University Press; 2006:95-128.
4. Hasle H. Myelodysplastic Syndrome. In: Pui C-H, ed. Childhood Leukemias, 2nd ed. Cambridge, UK: Cambridge University Press; 2006:548-570.
5. Yetgin S, Olcay L, Özsoylu Ş, Hiçsönmez G, Gürgey A, Tuncer AM. Retrospective analysis of 78 children with chronic idiopathic thrombocytopenic purpura: follow-up from 1976 to 1996. Pediatr Hematol Oncol. 1997;14:399-412.
6. Olcay L, Yetgin S, Okur H, Erdemli E. Rapid cell senescence and apoptosis in lymphocytes and granulocytes and absence of GM-CSF receptor in congenital dysgranulopoietic neutropenia. Leuk Res. 2007;32:235-242. (Pubitemid 351215544)
7. Kerr JFR. Definition of apoptosis and overview of its incidence. In: Lavin M, Watters D, eds. Cell Death: The Cellular & Molecular Biology of Apoptosis. Brisbane: Harwood Academic; 1993:1-19.
8. Thiele J, Lorenzen J, Manich B, Kvasnicka HM, Zirbes TK, Fischer R. Apoptosis (programmed cell death) in idiopathic (primary) osteo-/myelofibrosis: naked nuclei in megakaryopoiesis reveal features of para-apoptosis. Acta Haematol. 1997;97:137-143. (Pubitemid 27067410)
9. Martin SJ, Reutelingsperger CPM, Green DR. Annexin V: a specific probe for apoptotic cells. In: Cotter TG, Martin SJ, eds. Techniques in Apoptosis: A User's Guide. London: Portland Press; 1996:105-119.
10. Hicsonmez G, Cetin M, Yenicesu I, et al. Evaluation of children with myelodysplastic syndrome:importance of extramedullary disease as a presenting symptom. Leuk Lymphoma. 2001;42:665-674. (Pubitemid 32782774)
11. Olcay L, Yetgin S, Okur H, Erekul S, Tuncer M. Dysplastic changes in idiopathic thrombocytopenic purpura and the effect of corticosteroids to increase dysplasia and cause hyperdiploid macropolycytes. Am J Hematol. 2000;65:99-104.
12. Houwerzijl EJ, Blom NR, van der Want JJL, et al. Increased peripheral platelet destruction and caspase-3-independent programmed cell death of bone marrow megakaryocytes in myelodysplastic patients. Blood. 2005;105:3472-3479.
13. Hu T, Shi XD, Feng YL, et al. Comperative study on bone marrow megakaryocytes in children with thrombocytopenic purpura, aplastic anemia and myelodysplastic syndrome. Zhonghua Er Ke Za Zhi. 2005;43:183-187.
14. Raza A, Gezer S, Mundle S, et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood. 1995;86:268-726.
15. Houwerzijl EJ, Blom NR, van der Want JJL, et al. Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood. 2004;103:500-506.
16. Hofmann W-K, Kalina U, Koschmieder S, Seipelt G, Hoelzer D, Ottmann OG. Defective megakaryocytic development in myelodysplastic syndromes. Leuk Lymphoma. 2000;38:13-19. (Pubitemid 30224319)
17. Howard MR, Kesteven PJL. Sea blue histiocytosis: a common abnormality of the bone marrow in myelodysplastic syndromes. J Clin Pathol. 1993;46:1030-1032.
18. Aslan D, Yetgin S. Megakaryocyte emperipolesis in a child with chronic neutropenia: an unusual coexistence. Turk J Pediatr. 2001;43:255-256. (Pubitemid 33688182)
19. Bauer S, Khan A, Klein A, Starasoler L. Naked megakaryocyte nuclei as an indicator of human immunodeficiency virus infection. Arch Pathol Lab Med. 1992;116:1025-1029.
20. Gordon S, Lee S. Naked megakaryocyte nuclei in bone marrows of patients with acquired immunodeficiency syndrome: a somewhat specific finding. Modern Pathol. 1994;7:166-168.
21. Li X, Pu Q. Megakaryocytopoiesis and apoptosis in patients with myelodysplastic syndromes. Leuk Lymphoma. 2005;46:387-391. (Pubitemid 40220396)
22. Olsson B, Andersson P-O, Jacobsson S, Carlsson L, Wadenvik H. Disturbed apoptosis of T-cells in patients with active idiopathic thrombocytopenic purpura. Thromb Haemost. 2005;93:139-144. (Pubitemid 40124268)
23. Hamada K, Takahashi I, Matsuoka M, et al. Apoptosis of peripheral leukocytes in patients with myelodysplastic syndromes. Rinsho Ketsueki. 1998;39:1079-1084.
24. Fedorko ME, Lichtman MA. Megakaryocyte structure, maturation and ecology. In: Colman RW, ed. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia: JBLippincott, 1982:210-224.
25. Olney HJ, Le Beau MM. Cytogenetic abnormalities inmyelodysplastic syndromes. In: Greenberg PL, ed. Myelodysplastic Syndromes: Clinical and Biological Advances. Cambridge, UK: Cambridge University Press; 2006:95-128.
26. Hebbar M, Kaplan C, Caulier MT, et al. Low incidence of specific anti-platelet antibodies detected by the MAIPA assay in the serum of thrombocytopenic MDS patients and lack of correlation between platelet autoantibodies, platelet lifespan and response to danazol therapy. Br J Haematol. 1996;94:112-115. (Pubitemid 26232548)